Literature DB >> 2854322

A bi-functional reporter plasmid for the simultaneous transient expression assay of two herpes simplex virus promoters.

W M Flanagan1, E K Wagner.   

Abstract

We have constructed a transient expression vector (pCAL) containing two reporter genes, chloramphenicol acetyltransferase (CAT) and beta-galactosidase (beta-gal) for use in studying herpes simplex virus type 1 (HSV-1) promoter activity in mammalian cells. The construct was designed to be useful in analyzing the simultaneous expression from two different promoters. To test the utility of the vector, we used three HSV-1 promoters that had been characterized previously by workers in this laboratory. Two are early (beta) promoters, for alkaline exonuclease and deoxyuridine triphosphate nucleotidohydrolase; the third promoter controls the major capsid protein transcript and is late (beta gamma). The two different kinetic classes of promoters were ligated in a divergent orientation into pCAL and transfected into rabbit skin fibroblast. Transfected cells were then superinfected with low multiplicities of HSV-1; 18 hr later, we observed the simultaneous expression of both marker genes under control of the respective promoters. The usefulness of such a transient expression reporter vector is discussed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2854322     DOI: 10.1007/bf00125686

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  17 in total

1.  A genetic approach to promoter recognition during trans induction of viral gene expression.

Authors:  D M Coen; S P Weinheimer; S L McKnight
Journal:  Science       Date:  1986-10-03       Impact factor: 47.728

2.  A single regulatory region modulates both cis activation and trans activation of the herpes simplex virus VP5 promoter in transient-expression assays in vivo.

Authors:  E D Blair; E K Wagner
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

3.  Comparison of upstream sequence requirements for positive and negative regulation of a herpes simplex virus immediate-early gene by three virus-encoded trans-acting factors.

Authors:  P O'Hare; G S Hayward
Journal:  J Virol       Date:  1987-01       Impact factor: 5.103

4.  Cloning and characterization of the gene for Escherichia coli tryptophanyl-transfer ribonucleic acid synthetase.

Authors:  C V Hall; C Yanofsky
Journal:  J Bacteriol       Date:  1981-12       Impact factor: 3.490

5.  Detailed characterization of the mRNA mapping in the HindIII fragment K region of the herpes simplex virus type 1 genome.

Authors:  K P Anderson; R J Frink; G B Devi; B H Gaylord; R H Costa; E K Wagner
Journal:  J Virol       Date:  1981-03       Impact factor: 5.103

6.  Analysis of gene control signals by DNA fusion and cloning in Escherichia coli.

Authors:  M J Casadaban; S N Cohen
Journal:  J Mol Biol       Date:  1980-04       Impact factor: 5.469

7.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

8.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

9.  Virus-induced modification of the host cell is required for expression of the bacterial chloramphenicol acetyltransferase gene controlled by a late herpes simplex virus promoter (VP5).

Authors:  R H Costa; K G Draper; G Devi-Rao; R L Thompson; E K Wagner
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

10.  Expression and regulation of Escherichia coli lacZ gene fusions in mammalian cells.

Authors:  C V Hall; P E Jacob; G M Ringold; F Lee
Journal:  J Mol Appl Genet       Date:  1983
View more
  9 in total

1.  The kinetics of VP5 mRNA expression is not critical for viral replication in cultured cells.

Authors:  P T Lieu; E K Wagner
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

2.  Effect of genomic location on expression of beta-galactosidase mRNA controlled by the herpes simplex virus type 1 UL38 promoter.

Authors:  S A Goodart; J F Guzowski; M K Rice; E K Wagner
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

3.  Herpes simplex virus recombination vectors designed to allow insertion of modified promoters into transcriptionally "neutral" segments of the viral genome.

Authors:  J Singh; E K Wagner
Journal:  Virus Genes       Date:  1995       Impact factor: 2.332

4.  Mutational analysis of the herpes simplex virus type 1 strict late UL38 promoter/leader reveals two regions critical in transcriptional regulation.

Authors:  J F Guzowski; E K Wagner
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

5.  Optical imaging of targeted β-galactosidase in brain tumors to detect EGFR levels.

Authors:  Ann-Marie Broome; Gopal Ramamurthy; Kari Lavik; Alexander Liggett; Ian Kinstlinger; James Basilion
Journal:  Bioconjug Chem       Date:  2015-03-30       Impact factor: 4.774

6.  Induction of interleukin-8 gene expression is associated with herpes simplex virus infection of human corneal keratocytes but not human corneal epithelial cells.

Authors:  J E Oakes; C A Monteiro; C L Cubitt; R N Lausch
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

7.  Analysis of the herpes simplex virus type 1 promoter controlling the expression of UL38, a true late gene involved in capsid assembly.

Authors:  W M Flanagan; A G Papavassiliou; M Rice; L B Hecht; S Silverstein; E K Wagner
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

8.  The activity of the pseudorabies virus latency-associated transcript promoter is dependent on its genomic location in herpes simplex virus recombinants as well as on the type of cell infected.

Authors:  C J Huang; M K Rice; G B Devi-Rao; E K Wagner
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

9.  Relationship between polyadenylated and nonpolyadenylated herpes simplex virus type 1 latency-associated transcripts.

Authors:  G B Devi-Rao; S A Goodart; L M Hecht; R Rochford; M K Rice; E K Wagner
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.